| | |
Per Share and
Common stock purchase warrants |
| |
Per Pre-Funded
Warrant and Common stock purchase warrants |
| |
Total
|
| |||||||||
Public offering price
|
| | | $ | 3.50 | | | | | $ | 3.49 | | | | | $ | 7,000,000 | | |
Placement agent fees(1)
|
| | | $ | 0.2450 | | | | | $ | 0.2443 | | | | | $ | 490,000 | | |
Proceeds to us, before expenses
|
| | | $ | 3.255 | | | | | $ | 3.2457 | | | | | $ | 6,510,000 | | |
| | | | | i | | | |
| | | | | iii | | | |
| | | | | iii | | | |
| | | | | 1 | | | |
| | | | | 14 | | | |
| | | | | 16 | | | |
| | | | | 18 | | | |
| | | | | 28 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 35 | | | |
| | | | | 44 | | | |
| | | | | 52 | | | |
| | | | | 55 | | | |
| | | | | 55 | | |
| | |
Three Months
Ended March 31, |
| |
Years Ended
December 31, |
| ||||||||||||||||||
| | |
2023
|
| |
2022
|
| |
2022
|
| |
2021
|
| ||||||||||||
| | |
Unaudited
|
| | | | | | | | | | | | | |||||||||
Statement of Operations Data | | | | | | ||||||||||||||||||||
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development
|
| | | $ | 2,591,350 | | | | | $ | 1,881,576 | | | | | $ | 10,232,366 | | | | | $ | 2,753,966 | | |
General and administrative
|
| | | | 2,309,763 | | | | | | 1,595,926 | | | | | | 8,433,448 | | | | | | 3,397,169 | | |
Total operating expenses
|
| | | | 4,901,113 | | | | | | 3,477,502 | | | | | | 18,665,814 | | | | | | 6,151,135 | | |
Operating loss
|
| | | | (4,901,113) | | | | | | (3,477,502) | | | | | | (18,665,814) | | | | | | (6,151,135) | | |
Other income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | |
Change in fair value of derivative liabilities
|
| | | | — | | | | | | — | | | | | | — | | | | | | (867,000) | | |
Change in fair value of warranty liability
|
| | | | — | | | | | | — | | | | | | — | | | | | | (6,109) | | |
Grant income
|
| | | | 79,409 | | | | | | 6,990 | | | | | | 1,080,436 | | | | | | 278,333 | | |
Loss on sale of equipment
|
| | | | — | | | | | | — | | | | | | — | | | | | | (3,082) | | |
Interest expense
|
| | | | — | | | | | | — | | | | | | — | | | | | | (95,070) | | |
Interest income
|
| | | | 4,770 | | | | | | 442 | | | | | | 20,410 | | | | | | 664 | | |
Total other income (expense)
|
| | | | 84,179 | | | | | | 7,432 | | | | | | 1,100,846 | | | | | | (692,264) | | |
Loss before income taxes
|
| | | | (4,816,934) | | | | | | (3,470,070) | | | | | | (17,564,968) | | | | | | (6,843,399) | | |
Income tax expense (benefit)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss
|
| | | $ | (4,816,934) | | | | | $ | (3,470,070) | | | | | $ | (17,564,968) | | | | | $ | (6,843,399) | | |
Basic and diluted loss per common share(1)
|
| | | $ | (6.69) | | | | | $ | (5.35) | | | | | $ | (27.07) | | | | | $ | (16.24) | | |
Weighted average number of common shares outstanding, basic and diluted(1)
|
| | | | 720,019 | | | | | | 648,861 | | | | | | 648,861 | | | | | | 421,294 | | |
| | | | | | | | |
December 31,
|
| | | | |||||||||
| | |
March 31, 2023
|
| |
2022
|
| |
2021
|
| | |||||||||||
| | |
Unaudited
|
| | | | | | | | | | | | | | |||||
Balance Sheet Data | | | | | | | | | | | | | | | | | | | | | | |
Current assets
|
| | | $ | 4,346,623 | | | | | $ | 7,379,405 | | | | | $ | 22,732,175 | | | | | |
Total assets
|
| | | | 5,590,510 | | | | | | 7,587,986 | | | | | | 22,938,443 | | | | | |
Current liabilities
|
| | | | 5,449,489 | | | | | | 4,347,290 | | | | | | 2,534,097 | | | | | |
Total liabilities
|
| | | | 5,827,302 | | | | | | 4,347,290 | | | | | | 2,534,097 | | | | | |
Total stockholders’ equity (deficit)
|
| | | | (236,792) | | | | | | 3,240,696 | | | | | | 20,404,346 | | | | | |
|
Public offering price per share and accompanying common stock purchase warrant
|
| | | | | | | | | $ | 3.50 | | |
|
Pro forma net tangible book value per share at March 31, 2023
|
| | | $ | 0.31 | | | | | | | | |
|
Increase in book value per share attributable to new investors
|
| | | $ | 1.89 | | | | | | | | |
|
As adjusted pro forma net tangible book value per share after this offering
|
| | | $ | 2.20 | | | | | | | | |
|
Dilution per share to new investors
|
| | | | | | | | | $ | 1.30 | | |
| | |
Per Share and
Common stock purchase warrants |
| |
Per Pre-Funded
Warrant and Common stock purchase warrants |
| |
Total
|
| |||||||||
Offering Price
|
| | | $ | 3.50 | | | | | $ | 3.49 | | | | | $ | 7,000,000 | | |
Placement agent fees
|
| | | | 0.245 | | | | | | 0.2443 | | | | | $ | 490,000 | | |
Proceeds to us, before expenses
|
| | | $ | 3.255 | | | | | $ | 3.2457 | | | | | $ | 6,510,000 | | |